Although the study has been extended, October was the date for the primary data to be compiled, so I interpret that as to mean that we still have results reported by the end of Qtr. 1. Perhaps they felt the need to extend the trial to provide further support for the NDA as the results were not as robust as hoped for. Anyone care to comment?
News 
Market Data 
Discover 
